Showing results (311-320 of 530) with videos related to
Sort By:
Pageof 53
Rheumatology (Oxford, England)|December 26, 2015
Cardiovascular risk factor management in patients with RA compared to matched non-RA patientsEvo Alemao, Helene Cawston, Francois Bourhis, et al.Arthritis Care & Research|September 22, 2025
Development and External Validation of a Multivariable Predictive Model for Progression to Difficult-to-Treat Rheumatoid Arthritis in Biologic-Experienced PatientsMisti L Paudel, Nancy Shadick, Michael Weinblatt, et al.Arthritis Care & Research|November 8, 2011
Variation in initial kidney replacement therapy for end-stage renal disease due to lupus nephritis in the United StatesAmy Devlin, Sushrut S Waikar, Daniel H Solomon, et al.Pharmacoepidemiology and Drug Safety|March 17, 2012
New loop diuretic prescriptions may be an acute risk factor for falls in the nursing homeSarah D Berry, Murray A Mittleman, Yuqing Zhang, et al.The Journal of Rheumatology|November 3, 2019
Atrial Fibrillation/flutter Hospitalizations among US Medicaid Recipients with and without Systemic Lupus ErythematosusSarah K Chen, Medha Barbhaiya, Daniel H Solomon, et al.Pediatrics|April 14, 2010
Comparative safety of antidepressant agents for children and adolescents regarding suicidal actsSebastian Schneeweiss, Amanda R Patrick, Daniel H Solomon, et al.Journal of Clinical & Cellular Immunology|March 28, 2014
Erythropoiesis-stimulating Agent Use among Patients with Lupus Nephritis Approaching End-stage Renal DiseaseJosé A Gómez-Puerta, Sushrut S Waikar, Daniel H Solomon, et al.Annals of the Rheumatic Diseases|December 4, 2013
The comparative effectiveness of abatacept versus anti-tumour necrosis factor switching for rheumatoid arthritis patients previously treated with an anti-tumour necrosis factorLeslie R Harrold, George W Reed, Joel M Kremer, et al.Rheumatology (Oxford, England)|June 18, 2021
Adverse effects related to methotrexate polyglutamate levels: adjudicated results from the cardiovascular inflammation reduction trialChang Xu, Jacob Selhub, Paul Jacques, et al.The Journal of Clinical Endocrinology and Metabolism|January 3, 2020
Delayed Denosumab Injections and Bone Mineral Density Response: An Electronic Health Record-based StudyHouchen Lyu, Sizheng S Zhao, Kazuki Yoshida, et al.Pageof 53